搜尋
Nuvation Bio Inc
NUVB_t添加自選
0.005USD
0.0000.00%
收盤 （美東）報價延遲15分鐘
0.00總市值
--本益比TTM
關於 Nuvation Bio Inc 公司
Nuvation Bio Inc. 是一家生物製藥公司。該公司致力於通過開發差異化和治療候選藥物來解決腫瘤學中未滿足的需求。該公司正在推進多個臨牀階段候選藥物，包括 ROS1 抑制劑、突變異檸檬酸脫氫酶 1 (mIDH1) 抑制劑、溴結構域和額外末端 (BET) 抑制劑以及藥物-藥物偶聯物 (DDC)。其開發候選藥物組合包括塔雷替尼 (ROS1)、沙夫西地尼 (mIDH1)、NUV-868 (BET) 和 NUV-1511 (DDC)。塔雷替尼是一種口服、強效、中樞神經系統活性、選擇性 ROS1 抑制劑，專爲治療 ROS1 陽性非小細胞肺癌 (NSCLC) 而設計。 Safusidenib 是一種口服的強效靶向 mIDH1 抑制劑，目前正在全球 II 期試驗中對低級別 IDH1 突變型膠質瘤患者進行評估。NUV-868 是一種 BD2 選擇性口服小分子 BET 抑制劑，可抑制 BRD4。該公司正在對 NUV-1511 進行 I/II 期研究。
Nuvation Bio Inc簡介
公司代碼NUVB_t
公司名稱Nuvation Bio Inc
上市日期Jul 01, 2020
CEODr. David T. Hung, M.D.
員工數量- -
證券類型- -
年結日- -
公司地址357 Tehama Street, Floor 3
城市SAN FRANCISCO
上市交易所- -
國家United States of America
郵編94103
電話14157543517
網址https://www.nuvationbio.com/
公司代碼NUVB_t
上市日期Jul 01, 2020
CEODr. David T. Hung, M.D.
Nuvation Bio Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. David T. Hung, M.D.
Dr. David T. Hung, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Joe Rayne
Mr. Joe Rayne
Investor Relations
Investor Relations
--
--
Mr. Philippe Sauvage
Mr. Philippe Sauvage
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
--
--
Ms. Stacy Markel
Ms. Stacy Markel
Chief People Officer
Chief People Officer
--
--
Ms. Colleen Sjogren
Ms. Colleen Sjogren
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Gary Hattersley, Ph.D.
Dr. Gary Hattersley, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Moses Makunje, CPA
Mr. Moses Makunje, CPA
Principal Accounting Officer, Vice President - Finance
Principal Accounting Officer, Vice President - Finance
--
--
Ms. Kerry A. Wentworth
Ms. Kerry A. Wentworth
Chief Regulatory Officer
Chief Regulatory Officer
--
--
Dr. Robert Mashal, M.D.
Dr. Robert Mashal, M.D.
Independent Director
Independent Director
--
--
Mr. Kim D. Blickenstaff
Mr. Kim D. Blickenstaff
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. David T. Hung, M.D.
Dr. David T. Hung, M.D.
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Joe Rayne
Mr. Joe Rayne
Investor Relations
Investor Relations
--
--
Mr. Philippe Sauvage
Mr. Philippe Sauvage
Chief Financial Officer and Principal Financial Officer
Chief Financial Officer and Principal Financial Officer
--
--
Ms. Stacy Markel
Ms. Stacy Markel
Chief People Officer
Chief People Officer
--
--
Ms. Colleen Sjogren
Ms. Colleen Sjogren
Chief Commercial Officer
Chief Commercial Officer
--
--
Dr. Gary Hattersley, Ph.D.
Dr. Gary Hattersley, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
